急性严重性结肠炎试验:过去,现在和未来
Sailish Honap1,2, Vipul Jairath3,4, Bruce E Sands5
1King's College London, School of Immunology & Microbial Sciences, London, UK.
Gut
|June 4, 2024
概括
自20世纪90年代以来,急性严重性结肠炎 (ASUC) 治疗的进展有限. 本综述审查了住院ASUC患者的随机对照试验 (RCT),评估治疗疗效和试验演变.
科学领域:
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
- 医学研究方法学 医学研究方法学
背景情况:
- 急性严重性结肠炎 (ASUC) 具有显著的胆管切除和死亡风险.
- 1955年的皮质素试验确定了ASUC的第一线治疗和早期临床试验终点.
- 自1990年代末-2000年代初的因弗力西马布和环素试验以来,ASUC的药物开发进展有限.
研究的目的:
- 系统地审查所有针对住院严重性结肠炎 (UC) 患者的干预随机对照试验 (RCT).
- 提供从历史到当前疗法的ASUC治疗疗效的概述.
- 评估ASUC临床试验特征的演变,并确定未来的挑战和机遇.
主要方法:
- 对入院重症UC患者进行的干预随机对照试验 (RCT) 的系统审查.
- 对不同治疗时代的治疗疗效的分析.
- 评估随着时间的推移,研究群体,符合条件和研究设计的变化.
主要成果:
- 历史上的皮质素试验确立了基础治疗和终点.
- 20世纪90年代和2000年代的试验证明了因弗利西马布和环素的疗效.
- 尽管正在进行RCT,但新ASUC药物开发的近期进展有限.
结论:
- 该审查强调了ASUC药物开发的历史影响和随后的停滞.
- 了解试验设计的演变对于未来的研究至关重要.
- 克服临床试验计划中的挑战对于提供新型ASUC疗法至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease I: Ulcerative Colitis
162
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
162
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
Chronic Bowel Disorders: Introduction
440
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
440
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115


